RxDoctor Payments DataLook up a doctor →

Steven Zeig, MD

Nephrology · Hollywood, FLNPI 1982693719

Payments from drug & device makers

$14,275,363in general payments, 2019–2025

Across 740 payments — averaging $19,291 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$10.9M
  • CSL Behring$927K
  • Eli Lilly$569K
  • Astrazeneca UK Limited$531K
  • Amgen$461K
  • GSK$220K
  • plus $664K from 34 others
$15,300in research payments, 2019–2025

Across 3 payments — averaging $5100.09 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eli Lilly$15K

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$14,275,363 in reported general payments places this provider in the 95th percentile of 756 nephrology providers in Florida.

See all nephrology providers in Florida

Medicare billing

Part B allowed, 2024
$28,421
Medicare patients
39
Services billed
141

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other nephrology in Hollywood

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →